JPM23: New Biogen CEO Viehbacher aims to steer away from ‘melting iceberg’ and redefine the company zbecker Tue, 01/10/2023 – 10:35 More: JPM23: New Biogen CEO Viehbacher aims to steer away from 'melting iceberg' and redefine the company Source: fierce
read moreSpiral winds up for phase 2 sustained-release steroid trial with $8M financing ntaylor Tue, 01/10/2023 – 10:31 More: Spiral winds up for phase 2 sustained-release steroid trial with M financing Source: fierce
read moreCognos strikes SPAC merger to fund implantable drug delivery R&D ntaylor Tue, 01/10/2023 – 10:27 More: Cognos strikes SPAC merger to fund implantable drug delivery R&D Source: fierce
read moreEmerging technology could help patients who are unable to manage their type 1 diabetes More: Artificial pancreas technology set to change lives Source: News
read morePartnership offers treatment access to hundreds of patients across several European countries More: SIFI and Avanzanite announce AKANTIOR agreement Source: News
read moreJPM23: Is Novartis weighing respiratory, eye drug sell-offs after Sandoz? Not necessarily, CEO says aliu Mon, 01/09/2023 – 16:06 More: JPM23: Is Novartis weighing respiratory, eye drug sell-offs after Sandoz? Not necessarily, CEO says Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals